Ravelic, V., Burnstock, G., Receptors for purines and pyrimidines (1998) Pharmacol Rev, 50, pp. 413-492
Cattaneo, M., Gachet, C., ADP receptors and clinical bleeding disorders (1999) Arterioscler Thromb Vasc Biol, 19, pp. 2281-2285
Mahaut-Smith, M.P., Ennion, S.J., Rolf, M.G., Evans, R.J., ADP is not an agonist at P2X1 receptors: Evidence for separate receptors stimulated by ATP and ADP on human platelets (2000) Br J Pharmacol, 131, pp. 108-114
Rolf, M.G., Brearley, C.A., Mahaut-Smith, M.P., Platelet shape change evoked by selective activation of P2X1 purinoceptors with α,β-methylene ATP (2001) Thromb Haemost, 85, pp. 303-308
Oury, C., Toth-Zsamboki, E., Thys, C., Tytgat, J., Vermylen, J., Hoylaerts, M., The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen (2001) Thromb Haemost, 86, pp. 1264-1271
Boyer, J.L., Mohanram, A., Camaioni, E., Jacobson, K.A., Harden, T.K., Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxy-adenosine 3′,5′-biphosphate (1998) Br J Pharmacol, 124, pp. 1-3
Brown, S.G., King, B.F., Kim, Y.C., Jang, S.Y., Burnstock, G., Jacobson, K.A., Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors (2000) Drug Dev Res, 49, pp. 253-259
Boyer, J.L., Romero-Avila, T., Schchter, J.B., Harden, T.K., Identification of competitive antagonists of the P2Y1 receptor (1996) Mol Pharmacol, 50, pp. 1323-1329
Eckly, A., Gendrault, J.-L., Hechler, B., Cazenave, J.-P., Gachet, C., Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation (2001) Thromb Haemost, 85, pp. 694-701
Oury, C., Toth-Zsamboki, E., Van Geet, C., Thys, C., Wei, L., Nilius, B., Vermylen, J., Hoylaerts, M.F., A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue (2000) J Biol Chem, 275, pp. 22611-22614
Deckmyn, H., Stanssens, P., Hoet, B., Declerck, P.J., Lauwereys, M., Gansemans, Y., Tornai, I., Vermylen, J., An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function (1994) Br J Haematol, 87, pp. 562-571
